Biodexa Pharmaceuticals (BDRX) Short term Debt (2015 - 2025)
Biodexa Pharmaceuticals (BDRX) posted Short term Debt of $81140.1 for Q4 2025, down 89.62% sequentially from $781652.6 in Q4 2024, and down 89.62% YoY from $781652.6 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Short term Debt (2015 - 2025) Analysis & Trends
Biodexa Pharmaceuticals has reported Short term Debt for 11 years, with the latest figure at $81140.1 in Q4 2025.
- Quarterly Short term Debt fell 89.62% year-over-year to $81140.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $81140.1 (down 89.62% YoY) and the FY2025 annual result came in at $80429.1, down 89.71% from the prior year.
- Short term Debt eased to $81140.1 in Q4 2025 per BDRX's latest filing, from $781652.6 in the prior quarter.
- Over five years, Short term Debt peaked at $781652.6 in Q4 2024 and troughed at $81140.1 in Q4 2025.
- A 5-year average of $277237.0 and a median of $201016.6 in 2021 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2024 and 2025: Short term Debt jumped 272.65% in 2024, then plunged 89.62% in 2025.
- Over 5 years, Short term Debt stood at $196809.5 in 2021, then dropped by 4.05% to $188841.5 in 2022, then increased by 11.07% to $209754.7 in 2023, then surged by 272.65% to $781652.6 in 2024, then tumbled by 89.62% to $81140.1 in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $81140.1, $781652.6, and $209754.7 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81,140.14 |
| Dec 31, 2024 | 781,652.62 |
| Dec 31, 2023 | 209,754.67 |
| Jun 30, 2023 | 205,223.56 |
| Dec 31, 2022 | 188,841.46 |
| Dec 31, 2021 | 196,809.55 |
| Dec 31, 2020 | 264,090.20 |
| Dec 31, 2019 | 529,718.66 |
| Dec 31, 2018 | 473,530.34 |
| Dec 31, 2017 | 479,287.01 |
| Dec 31, 2016 | 668,853.58 |
| Dec 31, 2015 | 670,730.82 |